Large-Scale Candidate Gene Analysis of HDL Particle Features
暂无分享,去创建一个
Paul R. Burton | Nilesh J. Samani | Hans Robert Kalbitzer | Daniel I. Chasman | Lynda M. Rose | Klaus Stark | Christian Hengstenberg | Werner Kremer | Martin D. Tobin | Robert Clarke | M. Tobin | H. Kalbitzer | D. Chasman | P. Burton | N. Samani | P. Braund | C. Hengstenberg | M. Fischer | K. Stark | C. Nelson | S. Rafelt | R. Clarke | L. Rose | J. Hopewell | F. Huber | M. Tomaszewski | Christopher P. Nelson | Maciej Tomaszewski | B. Kaess | W. Kremer | Peter S. Braund | R. Debiec | Suzanne Rafelt | Marcus Fischer | Radoslaw Debiec | Bernhard M. Kaess | Robert Hardwick | Fritz Huber | Jemma Hopewell | Robert Hardwick | L. Rose | C. Nelson
[1] Tanya M. Teslovich,et al. Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.
[2] R. Collins,et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.
[3] P. Ridker,et al. Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis , 2009, PLoS genetics.
[4] J. Després,et al. HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. , 2009, Atherosclerosis.
[5] Kirsi H. Pietiläinen,et al. HDL Subspecies in Young Adult Twins: Heritability and Impact of Overweight , 2009, Obesity.
[6] S. Mora. Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use. , 2009, Circulation.
[7] H. Superko. Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful , 2009, Circulation.
[8] Samia Mora,et al. Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women , 2009, Circulation.
[9] N. Wareham,et al. High-Density Lipoprotein Particle Size and Concentration and Coronary Risk , 2009, Annals of Internal Medicine.
[10] R. Collins,et al. Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.
[11] Christian Gieger,et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts , 2009, Nature Genetics.
[12] Mark I. McCarthy,et al. Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies , 2008, PloS one.
[13] Nilesh J Samani,et al. Common Variants in Genes Underlying Monogenic Hypertension and Hypotension and Blood Pressure in the General Population , 2008, Hypertension.
[14] Hans Robert Kalbitzer,et al. The lipoprotein subfraction profile: heritability and identification of quantitative trait loci Published, JLR Papers in Press, December 28, 2007. , 2008, Journal of Lipid Research.
[15] A. Nègre-Salvayre,et al. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. , 2008, Atherosclerosis.
[16] Dolores Corella,et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.
[17] A. Stefanović,et al. Association of oxidative stress and PON1 with LDL and HDL particle size in middle‐aged subjects , 2007, European journal of clinical investigation.
[18] G. Abecasis,et al. Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. , 2007, Human molecular genetics.
[19] R. Mecham,et al. Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxa. , 2006, Human molecular genetics.
[20] D. Rader. Molecular regulation of HDL metabolism and function: implications for novel therapies. , 2006, The Journal of clinical investigation.
[21] Dean Y. Li,et al. Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[23] M. Ushio-Fukai,et al. Fibulin-5 Is a Novel Binding Protein for Extracellular Superoxide Dismutase , 2004, Circulation research.
[24] V. Sheffield,et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. , 2004, The New England journal of medicine.
[25] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] C. Curcio,et al. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. , 2003, The American journal of pathology.
[27] J. Colin,et al. Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels? , 2002, Clinica chimica acta; international journal of clinical chemistry.
[28] D. Freedman,et al. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. , 2002, The American journal of cardiology.
[29] Masashi Yanagisawa,et al. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo , 2002, Nature.
[30] K. Campbell,et al. Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy , 1999, Cell.
[31] M. Taniwaki,et al. DANCE, a Novel Secreted RGD Protein Expressed in Developing, Atherosclerotic, and Balloon-injured Arteries* , 1999, The Journal of Biological Chemistry.
[32] D. Freedman,et al. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[33] L. Almasy,et al. Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.
[34] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[35] D W Bennett,et al. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. , 1991, Clinical chemistry.
[36] D. Rao,et al. Twin study of genetic and environmental effects on lipid levels , 1988, Genetic epidemiology.